MedTrace Logo

A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

NCT06298006 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2025-02-11

No results posted yet for this study

Summary

The prospective, longitudinal, open observational study monitors patients with cognitive and neuropsychological symptoms after COVID-19 infection, in a longitudinal manner to see how the disease has affected their physical, psychological and cognitive function, their ability to be active, return to work, their health-related quality of life in correlation with potential diagnostic and prognostic markers.

Conditions

Interventions

OTHER

Follow-up

Follow-up of neurocognitive and psychiatric symptoms in Post COVID patients (baseline, 12 months, 24 months) in correlation with biomarkers using MRI, fMRI, neuropsychological testing, lab samples (blood, CSF, microbiota).

Sponsors & Collaborators

  • Örebro University, Sweden

    collaborator OTHER

  • Karolinska Institutet

    collaborator OTHER

  • Karolinska University Hospital

    collaborator OTHER

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Region Örebro County

    lead OTHER

Principal Investigators

  • Yvonne Freund-Levi, MD, PhD · Medical Faculty, Örebro University, Dept of Geriatrics, USÖ

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-22
Primary Completion
2026-05-31
Completion
2027-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06298006 on ClinicalTrials.gov